These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 31455678)

  • 21. Real-world utility of next-generation sequencing for targeted gene analysis and its application to treatment in lung adenocarcinoma.
    Kim JH; Yoon S; Lee DH; Jang SJ; Chun SM; Kim SW
    Cancer Med; 2021 May; 10(10):3197-3204. PubMed ID: 33960703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prognostic effect of single and multiple cancer-related somatic mutations in resected non-small-cell lung cancer.
    Jao K; Tomasini P; Kamel-Reid S; Korpanty GJ; Mascaux C; Sakashita S; Labbé C; Leighl NB; Liu G; Feld R; Bradbury PA; Hwang DM; Pintilie M; Tsao MS; Shepherd FA
    Lung Cancer; 2018 Sep; 123():22-29. PubMed ID: 30089591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High tumor mutation burden predicts favorable outcome among patients with aggressive histological subtypes of lung adenocarcinoma: A population-based single-institution study.
    Talvitie EM; Vilhonen H; Kurki S; Karlsson A; Orte K; Almangush A; Mohamed H; Liljeroos L; Singh Y; Leivo I; Laitinen T; Kallajoki M; Taimen P
    Neoplasia; 2020 Sep; 22(9):333-342. PubMed ID: 32585428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spectrum of gene mutations detected by next generation exome sequencing in brain metastases of lung adenocarcinoma.
    Preusser M; Berghoff AS; Koller R; Zielinski CC; Hainfellner JA; Liebmann-Reindl S; Popitsch N; Geier CB; Streubel B; Birner P
    Eur J Cancer; 2015 Sep; 51(13):1803-11. PubMed ID: 26164066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Underlying Tumor Genomics of Predominant Histologic Subtypes in Lung Adenocarcinoma.
    Caso R; Sanchez-Vega F; Tan KS; Mastrogiacomo B; Zhou J; Jones GD; Nguyen B; Schultz N; Connolly JG; Brandt WS; Bott MJ; Rocco G; Molena D; Isbell JM; Liu Y; Mayo MW; Adusumilli PS; Travis WD; Jones DR
    J Thorac Oncol; 2020 Dec; 15(12):1844-1856. PubMed ID: 32791233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive Molecular Characterization of Young Chinese Patients with Lung Adenocarcinoma Identified a Distinctive Genetic Profile.
    Hou H; Zhu H; Zhao H; Yan W; Wang Y; Jiang M; Liu B; Liu D; Zhou N; Zhang C; Li P; Chang L; Guan Y; Wang Z; Zhang X; Li Z; Fang B; Zhang X
    Oncologist; 2018 Sep; 23(9):1008-1015. PubMed ID: 29700208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutational profiling of lung adenocarcinoma in China detected by next-generation sequencing.
    Zhou X; Xu X; Tian Z; Xu WY; Cui Y
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2277-2287. PubMed ID: 32572558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Major challenges in accurate mutation detection of multifocal lung adenocarcinoma by next-generation sequencing.
    Qiu T; Li W; Zhang F; Wang B; Ying J
    Cancer Biol Ther; 2020; 21(2):170-177. PubMed ID: 31651223
    [No Abstract]   [Full Text] [Related]  

  • 29. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Early Invasive Lung Adenocarcinoma.
    Zhang C; Zhang J; Xu FP; Wang YG; Xie Z; Su J; Dong S; Nie Q; Shao Y; Zhou Q; Yang JJ; Yang XN; Zhang XC; Li Z; Wu YL; Zhong WZ
    J Thorac Oncol; 2019 Nov; 14(11):1912-1923. PubMed ID: 31446140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pre-operative plasma cell-free circulating tumor DNA and serum protein tumor markers as predictors of lung adenocarcinoma recurrence.
    Isaksson S; George AM; Jönsson M; Cirenajwis H; Jönsson P; Bendahl PO; Brunnström H; Staaf J; Saal LH; Planck M
    Acta Oncol; 2019 Aug; 58(8):1079-1086. PubMed ID: 31230502
    [No Abstract]   [Full Text] [Related]  

  • 31. Retrospective Multicenter Study Investigating the Role of Targeted Next-Generation Sequencing of Selected Cancer Genes in Mucinous Adenocarcinoma of the Lung.
    Righi L; Vatrano S; Di Nicolantonio F; Massa F; Rossi G; Cavazza A; Volante M; Votta A; Izzo S; Lo Iacono M; Ardissone F; Di Maio M; Novello S; Scagliotti GV; Papotti M
    J Thorac Oncol; 2016 Apr; 11(4):504-15. PubMed ID: 26774193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MET gene copy number gain is an independent poor prognostic marker in Korean stage I lung adenocarcinomas.
    Jin Y; Sun PL; Kim H; Seo AN; Jheon S; Lee CT; Chung JH
    Ann Surg Oncol; 2014 Feb; 21(2):621-8. PubMed ID: 24212721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Next-generation sequencing informs diagnosis and identifies unexpected therapeutic targets in lung squamous cell carcinomas.
    Sands JM; Nguyen T; Shivdasani P; Sacher AG; Cheng ML; Alden RS; Jänne PA; Kuo FC; Oxnard GR; Sholl LM
    Lung Cancer; 2020 Feb; 140():35-41. PubMed ID: 31855703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and pathological predictors of engraftment for patient-derived xenografts in lung adenocarcinoma.
    Ogawa H; Koga T; Pham NA; Bernards N; Gregor A; Sata Y; Kitazawa S; Hiraishi Y; Ishiwata T; Aragaki M; Yokote F; Effat A; Kazlovich K; Li Q; Hueniken K; Li M; Maniwa Y; Tsao MS; Yasufuku K
    Lung Cancer; 2024 Aug; 194():107863. PubMed ID: 38968761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genomic profiling of lung adenocarcinoma patients reveals therapeutic targets and confers clinical benefit when standard molecular testing is negative.
    Lim SM; Kim EY; Kim HR; Ali SM; Greenbowe JR; Shim HS; Chang H; Lim S; Paik S; Cho BC
    Oncotarget; 2016 Apr; 7(17):24172-8. PubMed ID: 26992220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive characterization of functional eRNAs in lung adenocarcinoma reveals novel regulators and a prognosis-related molecular subtype.
    Qin N; Ma Z; Wang C; Zhang E; Li Y; Huang M; Chen C; Zhang C; Fan J; Gu Y; Xu X; Yang L; Wei X; Yin R; Jiang Y; Dai J; Jin G; Xu L; Hu Z; Shen H; Ma H
    Theranostics; 2020; 10(24):11264-11277. PubMed ID: 33042282
    [No Abstract]   [Full Text] [Related]  

  • 37. The prognostic value of a Methylome-based Malignancy Density Scoring System to predict recurrence risk in early-stage Lung Adenocarcinoma.
    Yang L; Zhang J; Yang G; Xu H; Lin J; Shao L; Li J; Guo C; Du Y; Guo L; Li X; Han-Zhang H; Wang C; Chuai S; Ye J; Kang Q; Liu H; Ying J; Wang Y
    Theranostics; 2020; 10(17):7635-7644. PubMed ID: 32685009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comprehensive evaluation of clinicopathologic characteristics, molecular features and prognosis in lung adenocarcinoma with solid component.
    Li J; You W; Zheng D; Yan B; Ma X; Pan Y; Zhang Y; Li Y; Shen X; Cheng X; Sun Y; Chen H
    J Cancer Res Clin Oncol; 2018 Apr; 144(4):725-734. PubMed ID: 29368062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutations in the KEAP1-NFE2L2 Pathway Define a Molecular Subset of Rapidly Progressing Lung Adenocarcinoma.
    Goeman F; De Nicola F; Scalera S; Sperati F; Gallo E; Ciuffreda L; Pallocca M; Pizzuti L; Krasniqi E; Barchiesi G; Vici P; Barba M; Buglioni S; Casini B; Visca P; Pescarmona E; Mazzotta M; De Maria R; Fanciulli M; Ciliberto G; Maugeri-Saccà M
    J Thorac Oncol; 2019 Nov; 14(11):1924-1934. PubMed ID: 31323387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CT-based Radiogenomic Analysis of Clinical Stage I Lung Adenocarcinoma with Histopathologic Features and Oncologic Outcomes.
    Perez-Johnston R; Araujo-Filho JA; Connolly JG; Caso R; Whiting K; Tan KS; Zhou J; Gibbs P; Rekhtman N; Ginsberg MS; Jones DR
    Radiology; 2022 Jun; 303(3):664-672. PubMed ID: 35230187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.